Cargando…
Cardiotoxicity from neoadjuvant targeted treatment for breast cancer prior to surgery
Cancer treatment has been gradually shifting from non-specific cytotoxic agents to molecularly targeted drugs. Breast cancer (BC), a malignant tumor with one of the highest incidence worldwide, has seen a rapid development in terms of targeted therapies, leading to a radical change in the treatment...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992214/ https://www.ncbi.nlm.nih.gov/pubmed/36910540 http://dx.doi.org/10.3389/fcvm.2023.1078135 |